HWAM
CBAY

Hennion & Walsh Asset Management’s Cymabay Therapeutics CBAY Stock Holding History

Hennion & Walsh Asset Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-78,311
Closed -$1.85M – 893
2023
Q4 		$1.85M Buy
78,311
+5,472
+8% +$97.5K 0.11% 256
2023
Q3 		$1.09M Buy
72,839
+34,403
+90% +$456K 0.07% 341
2023
Q2 		$421K Buy
+38,436
New +$358K 0.03% 564

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Hennion & Walsh Asset Management's CBAY Position: Q1 2024 in Review

Hennion & Walsh Asset Management sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 78,311 shares — an estimated $1.85M sold.

Hennion & Walsh Asset Management first reported a position in CBAY in Q2 2023 and held it in 3 quarters. The position peaked at $1.85M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Hennion & Walsh Asset Management reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 78,311 Cymabay Therapeutics shares in Q1 2024, an estimated $1.85M.
  • Hennion & Walsh Asset Management first reported a position in Cymabay Therapeutics in Q2 2023 and held it in 3 quarters.
  • Hennion & Walsh Asset Management's Cymabay Therapeutics position peaked at $1.85M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Hennion & Walsh Asset Management's 13F filing for Q1 2024, filed 17 Apr 2024.